Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Treatment Cost

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Feb 19, 2023 11:12am

163 Views

Post# 35294271

RE:RE:RE:Treatment Cost

True frebeach, most don't have a spare $160K to spend on the treatment but insurance companies do. However because it is much less expensive than other treatments, insurance companies will pick up the coverage because it will actually save them money.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant